Clinical Trial Update: SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial for SB705498 in non-allergic rhinitis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• SB705498

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2018-01-29